Skip nav
Rephine Logo

The mutually-beneficial alliance will see Rephine take over the Dutch third-party audit service, while Ofidit’s audit reports will be featured in Rephine’s extensive library

Stevenage, UK – May 17th, 2022 – Rephine, a firm of deeply experienced GMP auditors specialising in pharma supply-chain quality assurance, has announced a new strategic partnership with Ofidit, which provides specialised GMP third-party auditing of active pharma ingredient (API) manufacturers worldwide. Ofidit, which has operations in Ter Apel, the Netherlands and Hangzhou, China, is the independent GMP audit programme of Laboratorium Ofichem BV, part of the Ofichem Group.

The mutually beneficial alliance will see Rephine take responsibility for Ofidit’s third-party audit service for customers, and in exchange Ofidit’s audit reports will be...

Read full release

Image Channel